Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Vivier

Showing results (11-20 of 316) with videos related to

Pageof 32
Sort By:
Current Opinion in Immunology|January 8, 2016
Editorial overview: Innate immunityEric Vivier, Ruslan Medzhitov
Nature Cancer|February 5, 2022
ISACs take a Toll on tumorsOlivier Demaria, Eric Vivier
F1000 Medicine Reports|June 10, 2011
Natural killer cell-based therapiesFrançois Romagné, Eric Vivier
Frontiers in Immunology|May 9, 2012
Natural killer cells: from basic research to treatmentsEric Vivier, Sophie Ugolini
Cell Host & Microbe|December 17, 2009
Regulatory natural killer cells: new players in the IL-10 anti-inflammatory responseEric Vivier, Sophie Ugolini
Science'S STKE : Signal Transduction Knowledge Environment|July 15, 2005
Natural killer cell receptor signaling pathway in mammalsFrédéric Vély, Eric Vivier
Nature Reviews. Immunology|March 25, 2004
Inhibitory NK-cell receptors on T cells: witness of the past, actors of the futureEric Vivier, Nicolas Anfossi
Nature Immunology|December 22, 2004
Innate and adaptive immunity: specificities and signaling hierarchies revisitedEric Vivier, Bernard Malissen
European Journal of Immunology|May 11, 2005
KARAP/DAP12/TYROBP: three names and a multiplicity of biological functionsElena Tomasello, Eric Vivier
Science (New York, N.Y.)|December 22, 2018
Chemotherapy and tumor immunityStéphanie Cornen, Eric Vivier
Pageof 32

Showing results (11-20 of 316) with videos related to

Sort By:
Pageof 32
Current Opinion in Immunology|January 8, 2016
Editorial overview: Innate immunityEric Vivier, Ruslan Medzhitov
Nature Cancer|February 5, 2022
ISACs take a Toll on tumorsOlivier Demaria, Eric Vivier
F1000 Medicine Reports|June 10, 2011
Natural killer cell-based therapiesFrançois Romagné, Eric Vivier
Frontiers in Immunology|May 9, 2012
Natural killer cells: from basic research to treatmentsEric Vivier, Sophie Ugolini
Cell Host & Microbe|December 17, 2009
Regulatory natural killer cells: new players in the IL-10 anti-inflammatory responseEric Vivier, Sophie Ugolini
Science'S STKE : Signal Transduction Knowledge Environment|July 15, 2005
Natural killer cell receptor signaling pathway in mammalsFrédéric Vély, Eric Vivier
Nature Reviews. Immunology|March 25, 2004
Inhibitory NK-cell receptors on T cells: witness of the past, actors of the futureEric Vivier, Nicolas Anfossi
Nature Immunology|December 22, 2004
Innate and adaptive immunity: specificities and signaling hierarchies revisitedEric Vivier, Bernard Malissen
European Journal of Immunology|May 11, 2005
KARAP/DAP12/TYROBP: three names and a multiplicity of biological functionsElena Tomasello, Eric Vivier
Science (New York, N.Y.)|December 22, 2018
Chemotherapy and tumor immunityStéphanie Cornen, Eric Vivier
Pageof 32